Fermenta Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

389.55

+1.50 (+0.39%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

389.55

+1.50 (+0.39%)
16:01 Dec 20

Quality

61/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

69/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	377.29	398.52	349.94	335.66	369.47
Operating Expenses +	295.63	337.07	332	308.15	318.76
Raw Material	163.12	146.89	131.04	104.02	122.19
Increase Decrease in Cost	-28.75	6.27	22.51	26.11	2.22
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	58.22	62.97	57.91	58.55	60.72
Miscellaneous Expenses	145.38	150.34	158.58	173.51	133.63
Operating Profit	81.66	61.45	17.94	27.51	50.71
Other Income	8.25	8.14	7.69	11.81	13
Depreciation	20.31	25.56	28.25	24.72	25.11
Interest	17.97	17.08	20.78	17.05	15.7
Profit before tax and exceptio..	51.63	26.94	-23.4	-2.45	22.9
Exceptional Items	0	0	-28.48	-7.43	0
PBT	51.63	26.94	-51.87	-9.87	22.9
Provision for Taxation	9.1	11.88	1.68	14.14	14.83
Net Profit	42.53	15.06	-53.55	-24.01	8.04
NET Profit after MI	45.51	15.45	-51.5	-23.06	8.27
EPS	15.69	5.33	-17.85	-7.99	2.93
Operating Profit Margin (%)	21.64	15.42	5.13	8.2	13.73
Net Profit Margin (%)	12.06	3.88	-14.72	-6.87	2.24

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	62.10	62.10	62.10	62.10	62.10
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	36.40	36.10	36.00	36.00	36.00
Others	1.50	1.80	1.90	1.90	1.90
Others	0.00	0.00	0.00	0.00	0.00